ArticleViewAbstractPharmacognosy Journal,2026,18,2,113-119.DOI:10.5530/pj.2026.18.124Published:June 2026Type:Original ArticleEffect of “Cuti Cuti” Extract (Blechnum Asplenioides) on Intestinal Motility in Albino MiceXiomara C. Benavente Chalco, Elena Hidalgo Agurto, Thalia Suarez Hernandez, Luis Lens-Sardon, and Juan Huaccho-Rojas Xiomara C. Benavente Chalco1,2, Elena Hidalgo Agurto3, Thalia Suarez Hernandez1, Luis Lens- Sardon4, Juan Huaccho-Rojas1* 1CHANGE Research Working Group, Carrera de Medicina Humana, Facultad de Ciencias de la Salud, Universidad Científica del Sur, Lima, Peru 2Sociedad Científica Médico Estudiantil Peruana, Lima, Perú. 3Facultad de Medicina Humana, Universidad de San Martín de Porres; Centro de Investigación de Medicina Tradicional y Farmacología, Lima, Perú. 4Universidad de San Martín de Porres, Facultad de Medicina Humana; Centro de Investigación de Medicina Tradicional y Farmacología. Lima, Perú Abstract:Introduction: Intestinal motility is regulated by the enteric nervous system, which responds to contractile changes. Constipation is one of its main disorders. Although prokinetic drugs are effective, they are associated with adverse effects. Therefore, the use of medicinal plants represents an innovative therapeutic alternative. Methods: An experimental study was conducted in 40 male albino Mus musculus mice. Two doses (250 and 500 mg/kg) of hydroalcoholic extract of Blechnum asplenioides were administered, as well as metoclopramide (10 mg/kg) and loperamide (5 mg/kg), distributed into five study groups. Gastric motility was assessed by measuring the distance traveled by activated charcoal 30 minutes after administration of the test substances. Results: ANOVA test revealed significant differences (P<0.05; 95% CI). The extract of Blechnum showed a prokinetic effect on gastric motility, with the 250 mg/kg dose counteracting the inhibitory action of loperamide. Discussion: The findings indicate that Blechnum asplenioides extract improves intestinal motility at evaluated doses, possibly due to compounds such as flavonoids and tannins. The significant difference between the 250 mg/kg dose and loperamide suggests antagonism to its inhibitory effect. However, no additional benefit was observed at higher doses, highlighting the importance of further studies to clarify mechanisms, safety, and clinical relevance. Extrapolation to humans should be made cautiously since animal models do not always replicate human physiology. Conclusion: The extract of Blechnum asplenioides demonstrates a prokinetic effect in albino mice, likely mediated by bioactive compounds and antioxidant properties. Further research is needed to confirm its mechanism, safety, and potential therapeutic application in humans. Keywords:Blechnum, intestinal motility, loperamide, Medicinal plants, metoclopramideView:PDF (241.37 KB) PDF Images ‹ The Effectiveness of Enteral Administration of Binahong Leaf Extract (Anredera cordifolia (Tenore) Steenis) on Blood Glucose Levels, MDA, and NGF in Wistar Rats with Diabetic Neuropathy Model up Integrating Ancient Therapeutics into Nutraceutical Oral Films for Alzheimer’s Neuroprotection ›